SSSS Study:Cost-effectiveness of simvastatin in the secondary prevention of coronary artery disease in Canada.

作者:国际循环网   日期:2004/10/12 0:00:00

国际循环网版权所有，谢绝任何形式转载，侵犯版权者必予法律追究。

OBJECTIVE: To determine the cost-effectiveness of simvastatin in the secondary prevention of coronary artery disease (CAD) in Canada. DESIGN: Cost-effectiveness model based on results from the Scandinavian Simvastatin Survival Study (45 study) and cost and resource utilization data from Canadian sources to simulate the economic impact of long-term simvastatin treatment (15 years). PATIENTS: Subjects with mean age of 59.4 years at recruitment into 4S study.

版面编辑：国际循环

相关搜索

SSSS研究